Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | APP | P05067 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.50 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.46 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10035317 | 0.97 | AVPR1A (0.54) | KDM4ENPC1RAB9AHSD17B10ALDH1A1 | |
| SCHEMBL10035360 | 0.97 | AVPR1A (0.54) | KDM4ENPC1RAB9AHSD17B10ALDH1A1 | |
| SCHEMBL17223083 | 0.94 | CYP2A6 (0.54) | KDM4EHSD17B10ALDH1A1APPAVPR1A | |
| SCHEMBL398821 | 0.90 | AVPR1A (0.56) | KDM4EHSD17B10ALDH1A1APPMEN1 | |
| SCHEMBL10035319 | 0.90 | AVPR1A (0.56) | KDM4EHSD17B10ALDH1A1APPMEN1 | |
| SCHEMBL10035330 | 0.90 | AVPR1A (0.56) | KDM4EHSD17B10ALDH1A1APPMEN1 | |
| SCHEMBL17231888 | 0.88 | CYP11B2 (0.52) | ALDH1A1APPMEN1AVPR1ACYP3A4 | |
| SCHEMBL10035328 | 0.85 | MKNK1 (0.53) | APPGAAKMT2AKDREPHB4 | |
| SCHEMBL10035332 | 0.85 | UCHL3 (0.47) | KDM4EALDH1A1APPGAAMEN1 | |
| SCHEMBL10035357 | 0.85 | OXTR (0.64) | KDM4ENPC1RAB9AHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101771-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device using triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8101771-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device using triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-20100079066-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-04-01 | — | — | US | disclosed |
| US-20100079066-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100079066-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Triazole Derivative | TTI1, TTI2, NLRP3 | KDM4E 3236/4885NPC1 4247/4885RAB9A 2624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.